Clinical Trial

Exploratory Study of Early Biomarkers Allowing Dynamic Assessment of Response to Treatment in Cancers of the Head and Neck

Study acronym: DART
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 9, 2024 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
DART is an exploratory molecular analysis study to assess potential early biomarkers of treatment response in squamous cell carcinoma of the head and neck (HNSCC)
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-12-06; most recent amendment 2024-08-07.
Trial Details
NCT Number NCT05644457
Lead Sponsor Royal Marsden NHS Foundation Trust
Conditions Head and Neck Cancer
Enrollment 50 participants
Start Date 2022-03-09
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2024-08-09